Document is current
Any future updates will be listed below
-
Authors
Arias-Tello, Piero A.
Coronado-Caceres, Carlos F.
Serrano-Sablich, Mario E.
Mantilla, Guillemo
Goicochea, Maria Teresa
Alarcon-Ruiz, Christoper A. https://orcid.org/0000-0003-3907-2784
- License Information
-
More Information
Article History
Received: 26 December 2025
Accepted: 27 January 2026
First Online: 7 February 2026
Declarations
:
: The present study adheres to the guidance listed in the latest version of the Declaration of Helsinki. The protocol for the present study was registered at Universidad CientÃfica del Sur (Registration Code: PRE-15-2025-00046) and it was waived for approval for Institutional Review Board. Protocol was also registered at PROSPERO online platform (CRD420250617669). No patient consent was necessary because we only included primary research studies with no contact with patients.
: Not applicable.
: MTG received a research grant from Pfizer (ID 89830415), received payment or honoraria from Abbvie, TEVA, and Pfizer, participated on Advisory Board from Abbvie and Pfizer, and was an IHS Co-opted trustee (2021 to 2023). The rest of the authors declare no conflicts of interest. The study was self-funded.
